img

Global Rotavirus Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Rotavirus Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Rotavirus vaccine is a vaccine used to protect against rotavirus infections, which are the leading cause of severe diarrhea among young children. The vaccines prevent 15–34% of severe diarrhea in the developing world and 37–96% of severe diarrhea in the developed world. The vaccines decrease the risk of death among young children due to diarrhea. Immunizing babies decreases rates of disease among older people and those who have not been immunized.

The World Health Organization (WHO) recommends that rotavirus vaccine be included in national routine vaccinations programs, especially in areas where the disease is common. This should be done along with promoting breastfeeding, handwashing, clean water and good sanitation. It is given by mouth and requires two or three doses. It should be given starting around six weeks of age.

The vaccines are safe. This includes their use in people with HIV/AIDS. An earlier vaccine that is no longer used was linked to intussusception, but the current versions are not clearly linked. Due to a potential risk they are not recommended in babies who have had intussusception. The vaccines are made from weakened rotavirus.

The vaccine first became available in the United States in 2006. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is between US$6.96 and $20.66 per dose as of 2014.In the United States it is more than US$200. As of 2013 there are two types of vaccine available globally, Rotarix and RotaTeq. Others are used in some countries.
The global Rotavirus Vaccines market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Rotavirus Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Rotavirus Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Rotavirus Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034..
The global key manufacturers of Rotavirus Vaccines include Bharat Biotech, Merck & Co., Inc, GlaxoSmithKline plc, Lanzhou Institute of Biological and Bharat Biotech International Limited, etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of Rotavirus Vaccines, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Rotavirus Vaccines by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Rotavirus Vaccines market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Rotavirus Vaccines market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Bharat Biotech
Merck & Co., Inc
GlaxoSmithKline plc
Lanzhou Institute of Biological
Bharat Biotech International Limited
By Type
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou lamb
Others
By Application
Adult
Pediatric
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Rotavirus Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Rotavirus Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rotavirus Vaccines sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Rotavirus Vaccines Definition
1.2 Market by Type
1.2.1 Global Rotavirus Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Rotarix
1.2.3 RotaTeq
1.2.4 Rotavac
1.2.5 Rotavin-M1
1.2.6 Lanzhou lamb
1.2.7 Others
1.3 Market Segment by Application
1.3.1 Global Rotavirus Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Adult
1.3.3 Pediatric
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Rotavirus Vaccines Sales
2.1 Global Rotavirus Vaccines Revenue Estimates and Forecasts 2018-2034
2.2 Global Rotavirus Vaccines Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Rotavirus Vaccines Revenue by Region
2.3.1 Global Rotavirus Vaccines Revenue by Region (2018-2024)
2.3.2 Global Rotavirus Vaccines Revenue by Region (2024-2034)
2.4 Global Rotavirus Vaccines Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Rotavirus Vaccines Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Rotavirus Vaccines Sales Quantity by Region
2.6.1 Global Rotavirus Vaccines Sales Quantity by Region (2018-2024)
2.6.2 Global Rotavirus Vaccines Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Rotavirus Vaccines Sales Quantity by Manufacturers
3.1.1 Global Rotavirus Vaccines Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Rotavirus Vaccines Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Rotavirus Vaccines Sales in 2022
3.2 Global Rotavirus Vaccines Revenue by Manufacturers
3.2.1 Global Rotavirus Vaccines Revenue by Manufacturers (2018-2024)
3.2.2 Global Rotavirus Vaccines Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Rotavirus Vaccines Revenue in 2022
3.3 Global Rotavirus Vaccines Sales Price by Manufacturers
3.4 Global Key Players of Rotavirus Vaccines, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Rotavirus Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Rotavirus Vaccines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Rotavirus Vaccines, Product Offered and Application
3.8 Global Key Manufacturers of Rotavirus Vaccines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Rotavirus Vaccines Sales Quantity by Type
4.1.1 Global Rotavirus Vaccines Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Rotavirus Vaccines Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Rotavirus Vaccines Sales Quantity Market Share by Type (2018-2034)
4.2 Global Rotavirus Vaccines Revenue by Type
4.2.1 Global Rotavirus Vaccines Historical Revenue by Type (2018-2024)
4.2.2 Global Rotavirus Vaccines Forecasted Revenue by Type (2024-2034)
4.2.3 Global Rotavirus Vaccines Revenue Market Share by Type (2018-2034)
4.3 Global Rotavirus Vaccines Price by Type
4.3.1 Global Rotavirus Vaccines Price by Type (2018-2024)
4.3.2 Global Rotavirus Vaccines Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Rotavirus Vaccines Sales Quantity by Application
5.1.1 Global Rotavirus Vaccines Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Rotavirus Vaccines Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Rotavirus Vaccines Sales Quantity Market Share by Application (2018-2034)
5.2 Global Rotavirus Vaccines Revenue by Application
5.2.1 Global Rotavirus Vaccines Historical Revenue by Application (2018-2024)
5.2.2 Global Rotavirus Vaccines Forecasted Revenue by Application (2024-2034)
5.2.3 Global Rotavirus Vaccines Revenue Market Share by Application (2018-2034)
5.3 Global Rotavirus Vaccines Price by Application
5.3.1 Global Rotavirus Vaccines Price by Application (2018-2024)
5.3.2 Global Rotavirus Vaccines Price Forecast by Application (2024-2034)
6 North America
6.1 North America Rotavirus Vaccines Sales by Company
6.1.1 North America Rotavirus Vaccines Revenue by Company (2018-2024)
6.1.2 North America Rotavirus Vaccines Sales Quantity by Company (2018-2024)
6.2 North America Rotavirus Vaccines Market Size by Type
6.2.1 North America Rotavirus Vaccines Sales Quantity by Type (2018-2034)
6.2.2 North America Rotavirus Vaccines Revenue by Type (2018-2034)
6.3 North America Rotavirus Vaccines Market Size by Application
6.3.1 North America Rotavirus Vaccines Sales Quantity by Application (2018-2034)
6.3.2 North America Rotavirus Vaccines Revenue by Application (2018-2034)
6.4 North America Rotavirus Vaccines Market Size by Country
6.4.1 North America Rotavirus Vaccines Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Rotavirus Vaccines Revenue by Country (2018-2034)
6.4.3 North America Rotavirus Vaccines Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Rotavirus Vaccines Sales by Company
7.1.1 Europe Rotavirus Vaccines Sales Quantity by Company (2018-2024)
7.1.2 Europe Rotavirus Vaccines Revenue by Company (2018-2024)
7.2 Europe Rotavirus Vaccines Market Size by Type
7.2.1 Europe Rotavirus Vaccines Sales Quantity by Type (2018-2034)
7.2.2 Europe Rotavirus Vaccines Revenue by Type (2018-2034)
7.3 Europe Rotavirus Vaccines Market Size by Application
7.3.1 Europe Rotavirus Vaccines Sales Quantity by Application (2018-2034)
7.3.2 Europe Rotavirus Vaccines Revenue by Application (2018-2034)
7.4 Europe Rotavirus Vaccines Market Size by Country
7.4.1 Europe Rotavirus Vaccines Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Rotavirus Vaccines Revenue by Country (2018-2034)
7.4.3 Europe Rotavirus Vaccines Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Rotavirus Vaccines Sales by Company
8.1.1 China Rotavirus Vaccines Sales Quantity by Company (2018-2024)
8.1.2 China Rotavirus Vaccines Revenue by Company (2018-2024)
8.2 China Rotavirus Vaccines Market Size by Type
8.2.1 China Rotavirus Vaccines Sales Quantity by Type (2018-2034)
8.2.2 China Rotavirus Vaccines Revenue by Type (2018-2034)
8.3 China Rotavirus Vaccines Market Size by Application
8.3.1 China Rotavirus Vaccines Sales Quantity by Application (2018-2034)
8.3.2 China Rotavirus Vaccines Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Rotavirus Vaccines Sales by Company
9.1.1 APAC Rotavirus Vaccines Sales Quantity by Company (2018-2024)
9.1.2 APAC Rotavirus Vaccines Revenue by Company (2018-2024)
9.2 APAC Rotavirus Vaccines Market Size by Type
9.2.1 APAC Rotavirus Vaccines Sales Quantity by Type (2018-2034)
9.2.2 APAC Rotavirus Vaccines Revenue by Type (2018-2034)
9.3 APAC Rotavirus Vaccines Market Size by Application
9.3.1 APAC Rotavirus Vaccines Sales Quantity by Application (2018-2034)
9.3.2 APAC Rotavirus Vaccines Revenue by Application (2018-2034)
9.4 APAC Rotavirus Vaccines Market Size by Region
9.4.1 APAC Rotavirus Vaccines Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Rotavirus Vaccines Revenue by Region (2018-2034)
9.4.3 APAC Rotavirus Vaccines Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Rotavirus Vaccines Sales by Company
10.1.1 Middle East, Africa and Latin America Rotavirus Vaccines Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Rotavirus Vaccines Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Rotavirus Vaccines Market Size by Type
10.2.1 Middle East, Africa and Latin America Rotavirus Vaccines Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Rotavirus Vaccines Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Rotavirus Vaccines Market Size by Application
10.3.1 Middle East, Africa and Latin America Rotavirus Vaccines Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Rotavirus Vaccines Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Rotavirus Vaccines Market Size by Country
10.4.1 Middle East, Africa and Latin America Rotavirus Vaccines Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Rotavirus Vaccines Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Rotavirus Vaccines Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Bharat Biotech
11.1.1 Bharat Biotech Company Information
11.1.2 Bharat Biotech Overview
11.1.3 Bharat Biotech Rotavirus Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Bharat Biotech Rotavirus Vaccines Products and Services
11.1.5 Bharat Biotech Rotavirus Vaccines SWOT Analysis
11.1.6 Bharat Biotech Recent Developments
11.2 Merck & Co., Inc
11.2.1 Merck & Co., Inc Company Information
11.2.2 Merck & Co., Inc Overview
11.2.3 Merck & Co., Inc Rotavirus Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Merck & Co., Inc Rotavirus Vaccines Products and Services
11.2.5 Merck & Co., Inc Rotavirus Vaccines SWOT Analysis
11.2.6 Merck & Co., Inc Recent Developments
11.3 GlaxoSmithKline plc
11.3.1 GlaxoSmithKline plc Company Information
11.3.2 GlaxoSmithKline plc Overview
11.3.3 GlaxoSmithKline plc Rotavirus Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 GlaxoSmithKline plc Rotavirus Vaccines Products and Services
11.3.5 GlaxoSmithKline plc Rotavirus Vaccines SWOT Analysis
11.3.6 GlaxoSmithKline plc Recent Developments
11.4 Lanzhou Institute of Biological
11.4.1 Lanzhou Institute of Biological Company Information
11.4.2 Lanzhou Institute of Biological Overview
11.4.3 Lanzhou Institute of Biological Rotavirus Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Lanzhou Institute of Biological Rotavirus Vaccines Products and Services
11.4.5 Lanzhou Institute of Biological Rotavirus Vaccines SWOT Analysis
11.4.6 Lanzhou Institute of Biological Recent Developments
11.5 Bharat Biotech International Limited
11.5.1 Bharat Biotech International Limited Company Information
11.5.2 Bharat Biotech International Limited Overview
11.5.3 Bharat Biotech International Limited Rotavirus Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Bharat Biotech International Limited Rotavirus Vaccines Products and Services
11.5.5 Bharat Biotech International Limited Rotavirus Vaccines SWOT Analysis
11.5.6 Bharat Biotech International Limited Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Rotavirus Vaccines Value Chain Analysis
12.2 Rotavirus Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Rotavirus Vaccines Production Mode & Process
12.4 Rotavirus Vaccines Sales and Marketing
12.4.1 Rotavirus Vaccines Sales Channels
12.4.2 Rotavirus Vaccines Distributors
12.5 Rotavirus Vaccines Customers
13 Market Dynamics
13.1 Rotavirus Vaccines Industry Trends
13.2 Rotavirus Vaccines Market Drivers
13.3 Rotavirus Vaccines Market Challenges
13.4 Rotavirus Vaccines Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Rotavirus Vaccines Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Rotarix
Table 3. Major Manufacturers of RotaTeq
Table 4. Major Manufacturers of Rotavac
Table 5. Major Manufacturers of Rotavin-M1
Table 6. Major Manufacturers of Lanzhou lamb
Table 7. Major Manufacturers of Others
Table 8. Global Rotavirus Vaccines Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 9. Global Rotavirus Vaccines Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 10. Global Rotavirus Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 11. Global Rotavirus Vaccines Revenue Market Share by Region (2018-2024)
Table 12. Global Rotavirus Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 13. Global Rotavirus Vaccines Revenue Market Share by Region (2024-2034)
Table 14. Global Rotavirus Vaccines Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Units)
Table 15. Global Rotavirus Vaccines Sales by Region (2018-2024) & (K Units)
Table 16. Global Rotavirus Vaccines Sales Market Share by Region (2018-2024)
Table 17. Global Rotavirus Vaccines Sales by Region (2024-2034) & (K Units)
Table 18. Global Rotavirus Vaccines Sales Market Share by Region (2024-2034)
Table 19. Global Rotavirus Vaccines Sales Quantity by Manufacturers (2018-2024) & (K Units)
Table 20. Global Rotavirus Vaccines Sales Quantity Share by Manufacturers (2018-2024)
Table 21. Global Rotavirus Vaccines Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 22. Global Rotavirus Vaccines Revenue Share by Manufacturers (2018-2024)
Table 23. Global Rotavirus Vaccines Price by Manufacturers 2018-2024 (USD/Unit)
Table 24. Global Key Players of Rotavirus Vaccines, Industry Ranking, 2021 VS 2022
Table 25. Global Rotavirus Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Rotavirus Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rotavirus Vaccines as of 2022)
Table 27. Global Key Manufacturers of Rotavirus Vaccines, Manufacturing Base Distribution and Headquarters
Table 28. Global Key Manufacturers of Rotavirus Vaccines, Product Offered and Application
Table 29. Global Key Manufacturers of Rotavirus Vaccines, Date of Enter into This Industry
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Rotavirus Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 32. Global Rotavirus Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 33. Global Rotavirus Vaccines Sales Quantity Share by Type (2018-2024)
Table 34. Global Rotavirus Vaccines Sales Quantity Share by Type (2024-2034)
Table 35. Global Rotavirus Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 36. Global Rotavirus Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 37. Global Rotavirus Vaccines Revenue Share by Type (2018-2024)
Table 38. Global Rotavirus Vaccines Revenue Share by Type (2024-2034)
Table 39. Rotavirus Vaccines Price by Type (2018-2024) & (USD/Unit)
Table 40. Global Rotavirus Vaccines Price Forecast by Type (2024-2034) & (USD/Unit)
Table 41. Global Rotavirus Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 42. Global Rotavirus Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 43. Global Rotavirus Vaccines Sales Quantity Share by Application (2018-2024)
Table 44. Global Rotavirus Vaccines Sales Quantity Share by Application (2024-2034)
Table 45. Global Rotavirus Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 46. Global Rotavirus Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 47. Global Rotavirus Vaccines Revenue Share by Application (2018-2024)
Table 48. Global Rotavirus Vaccines Revenue Share by Application (2024-2034)
Table 49. Rotavirus Vaccines Price by Application (2018-2024) & (USD/Unit)
Table 50. Global Rotavirus Vaccines Price Forecast by Application (2024-2034) & (USD/Unit)
Table 51. North America Rotavirus Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 52. North America Rotavirus Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 53. North America Rotavirus Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 54. North America Rotavirus Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 55. North America Rotavirus Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 56. North America Rotavirus Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 57. North America Rotavirus Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 58. North America Rotavirus Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 59. North America Rotavirus Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 60. North America Rotavirus Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 61. North America Rotavirus Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 62. North America Rotavirus Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 63. North America Rotavirus Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 64. North America Rotavirus Vaccines Sales Quantity by Country (2018-2024) & (K Units)
Table 65. North America Rotavirus Vaccines Sales Quantity by Country (2024-2034) & (K Units)
Table 66. Europe Rotavirus Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 67. Europe Rotavirus Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 68. Europe Rotavirus Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 69. Europe Rotavirus Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 70. Europe Rotavirus Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 71. Europe Rotavirus Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 72. Europe Rotavirus Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 73. Europe Rotavirus Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 74. Europe Rotavirus Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 75. Europe Rotavirus Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 76. Europe Rotavirus Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 77. Europe Rotavirus Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 78. Europe Rotavirus Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 79. Europe Rotavirus Vaccines Sales Quantity by Country (2018-2024) & (K Units)
Table 80. Europe Rotavirus Vaccines Sales Quantity by Country (2024-2034) & (K Units)
Table 81. China Rotavirus Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 82. China Rotavirus Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 83. China Rotavirus Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 84. China Rotavirus Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 85. China Rotavirus Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 86. China Rotavirus Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 87. China Rotavirus Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 88. China Rotavirus Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 89. China Rotavirus Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 90. China Rotavirus Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 91. APAC Rotavirus Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 92. APAC Rotavirus Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 93. APAC Rotavirus Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 94. APAC Rotavirus Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 95. APAC Rotavirus Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 96. APAC Rotavirus Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 97. APAC Rotavirus Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 98. APAC Rotavirus Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 99. APAC Rotavirus Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 100. APAC Rotavirus Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 101. APAC Rotavirus Vaccines Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 102. APAC Rotavirus Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 103. APAC Rotavirus Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 104. APAC Rotavirus Vaccines Sales Quantity by Region (2018-2024) & (K Units)
Table 105. APAC Rotavirus Vaccines Sales Quantity by Region (2024-2034) & (K Units)
Table 106. Middle East, Africa and Latin America Rotavirus Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Rotavirus Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 108. Middle East, Africa and Latin America Rotavirus Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 109. Middle East, Africa and Latin America Rotavirus Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 110. Middle East, Africa and Latin America Rotavirus Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 111. Middle East, Africa and Latin America Rotavirus Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Rotavirus Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 113. Middle East, Africa and Latin America Rotavirus Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 114. Middle East, Africa and Latin America Rotavirus Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 115. Middle East, Africa and Latin America Rotavirus Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 116. Middle East, Africa and Latin America Rotavirus Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 117. Middle East, Africa and Latin America Rotavirus Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 118. Middle East, Africa and Latin America Rotavirus Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 119. Middle East, Africa and Latin America Rotavirus Vaccines Sales Quantity by Country (2018-2024) & (K Units)
Table 120. Middle East, Africa and Latin America Rotavirus Vaccines Sales Quantity by Country (2024-2034) & (K Units)
Table 121. Bharat Biotech Company Information
Table 122. Bharat Biotech Description and Overview
Table 123. Bharat Biotech Rotavirus Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 124. Bharat Biotech Rotavirus Vaccines Product and Services
Table 125. Bharat Biotech Rotavirus Vaccines SWOT Analysis
Table 126. Bharat Biotech Recent Developments
Table 127. Merck & Co., Inc Company Information
Table 128. Merck & Co., Inc Description and Overview
Table 129. Merck & Co., Inc Rotavirus Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 130. Merck & Co., Inc Rotavirus Vaccines Product and Services
Table 131. Merck & Co., Inc Rotavirus Vaccines SWOT Analysis
Table 132. Merck & Co., Inc Recent Developments
Table 133. GlaxoSmithKline plc Company Information
Table 134. GlaxoSmithKline plc Description and Overview
Table 135. GlaxoSmithKline plc Rotavirus Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 136. GlaxoSmithKline plc Rotavirus Vaccines Product and Services
Table 137. GlaxoSmithKline plc Rotavirus Vaccines SWOT Analysis
Table 138. GlaxoSmithKline plc Recent Developments
Table 139. Lanzhou Institute of Biological Company Information
Table 140. Lanzhou Institute of Biological Description and Overview
Table 141. Lanzhou Institute of Biological Rotavirus Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 142. Lanzhou Institute of Biological Rotavirus Vaccines Product and Services
Table 143. Lanzhou Institute of Biological Rotavirus Vaccines SWOT Analysis
Table 144. Lanzhou Institute of Biological Recent Developments
Table 145. Bharat Biotech International Limited Company Information
Table 146. Bharat Biotech International Limited Description and Overview
Table 147. Bharat Biotech International Limited Rotavirus Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 148. Bharat Biotech International Limited Rotavirus Vaccines Product and Services
Table 149. Bharat Biotech International Limited Rotavirus Vaccines SWOT Analysis
Table 150. Bharat Biotech International Limited Recent Developments
Table 151. Key Raw Materials Lists
Table 152. Raw Materials Key Suppliers Lists
Table 153. Rotavirus Vaccines Distributors List
Table 154. Rotavirus Vaccines Customers List
Table 155. Rotavirus Vaccines Market Trends
Table 156. Rotavirus Vaccines Market Drivers
Table 157. Rotavirus Vaccines Market Challenges
Table 158. Rotavirus Vaccines Market Restraints
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Rotavirus Vaccines Product Picture
Figure 2. Global Rotavirus Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Rotavirus Vaccines Market Share by Type in 2022 & 2034
Figure 4. Rotarix Product Picture
Figure 5. RotaTeq Product Picture
Figure 6. Rotavac Product Picture
Figure 7. Rotavin-M1 Product Picture
Figure 8. Lanzhou lamb Product Picture
Figure 9. Others Product Picture
Figure 10. Global Rotavirus Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 11. Global Rotavirus Vaccines Market Share by Application in 2022 & 2034
Figure 12. Adult
Figure 13. Pediatric
Figure 14. Rotavirus Vaccines Report Years Considered
Figure 15. Global Rotavirus Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 16. Global Rotavirus Vaccines Revenue 2018-2034 (US$ Million)
Figure 17. Global Rotavirus Vaccines Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 18. Global Rotavirus Vaccines Sales Quantity 2018-2034 (K Units)
Figure 19. Global Rotavirus Vaccines Sales Quantity Market Share by Region (2018-2024)
Figure 20. Global Rotavirus Vaccines Sales Quantity Market Share by Region (2024-2034)
Figure 21. North America Rotavirus Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 22. North America Rotavirus Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 23. Europe Rotavirus Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 24. Europe Rotavirus Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 25. China Rotavirus Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 26. China Rotavirus Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 27. APAC Rotavirus Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 28. APAC Rotavirus Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Rotavirus Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 30. Middle East, Africa and Latin America Rotavirus Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 31. The Top 10 and Top 5 Players Market Share by Rotavirus Vaccines Sales Quantity in 2022
Figure 32. The Top 10 and Top 5 Players Market Share by Rotavirus Vaccines Revenue in 2022
Figure 33. Rotavirus Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Global Rotavirus Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 35. Global Rotavirus Vaccines Revenue Market Share by Type (2018-2034)
Figure 36. Global Rotavirus Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 37. Global Rotavirus Vaccines Revenue Market Share by Application (2018-2034)
Figure 38. North America Rotavirus Vaccines Revenue Market Share by Company in 2022
Figure 39. North America Rotavirus Vaccines Sales Quantity Market Share by Company in 2022
Figure 40. North America Rotavirus Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 41. North America Rotavirus Vaccines Revenue Market Share by Type (2018-2034)
Figure 42. North America Rotavirus Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 43. North America Rotavirus Vaccines Revenue Market Share by Application (2018-2034)
Figure 44. North America Rotavirus Vaccines Revenue Share by Country (2018-2034)
Figure 45. North America Rotavirus Vaccines Sales Quantity Share by Country (2018-2034)
Figure 46. U.S. Rotavirus Vaccines Revenue (2018-2034) & (US$ Million)
Figure 47. Canada Rotavirus Vaccines Revenue (2018-2034) & (US$ Million)
Figure 48. Europe Rotavirus Vaccines Sales Quantity Market Share by Company in 2022
Figure 49. Europe Rotavirus Vaccines Revenue Market Share by Company in 2022
Figure 50. Europe Rotavirus Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 51. Europe Rotavirus Vaccines Revenue Market Share by Type (2018-2034)
Figure 52. Europe Rotavirus Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 53. Europe Rotavirus Vaccines Revenue Market Share by Application (2018-2034)
Figure 54. Europe Rotavirus Vaccines Revenue Share by Country (2018-2034)
Figure 55. Europe Rotavirus Vaccines Sales Quantity Share by Country (2018-2034)
Figure 56. Germany Rotavirus Vaccines Revenue (2018-2034) & (US$ Million)
Figure 57. France Rotavirus Vaccines Revenue (2018-2034) & (US$ Million)
Figure 58. U.K. Rotavirus Vaccines Revenue (2018-2034) & (US$ Million)
Figure 59. Italy Rotavirus Vaccines Revenue (2018-2034) & (US$ Million)
Figure 60. Russia Rotavirus Vaccines Revenue (2018-2034) & (US$ Million)
Figure 61. China Rotavirus Vaccines Sales Quantity Market Share by Company in 2022
Figure 62. China Rotavirus Vaccines Revenue Market Share by Company in 2022
Figure 63. China Rotavirus Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 64. China Rotavirus Vaccines Revenue Market Share by Type (2018-2034)
Figure 65. China Rotavirus Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 66. China Rotavirus Vaccines Revenue Market Share by Application (2018-2034)
Figure 67. APAC Rotavirus Vaccines Sales Quantity Market Share by Company in 2022
Figure 68. APAC Rotavirus Vaccines Revenue Market Share by Company in 2022
Figure 69. APAC Rotavirus Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 70. APAC Rotavirus Vaccines Revenue Market Share by Type (2018-2034)
Figure 71. APAC Rotavirus Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 72. APAC Rotavirus Vaccines Revenue Market Share by Application (2018-2034)
Figure 73. APAC Rotavirus Vaccines Revenue Share by Region (2018-2034)
Figure 74. APAC Rotavirus Vaccines Sales Quantity Share by Region (2018-2034)
Figure 75. Japan Rotavirus Vaccines Revenue (2018-2034) & (US$ Million)
Figure 76. South Korea Rotavirus Vaccines Revenue (2018-2034) & (US$ Million)
Figure 77. China Taiwan Rotavirus Vaccines Revenue (2018-2034) & (US$ Million)
Figure 78. Southeast Asia Rotavirus Vaccines Revenue (2018-2034) & (US$ Million)
Figure 79. India Rotavirus Vaccines Revenue (2018-2034) & (US$ Million)
Figure 80. Middle East, Africa and Latin America Rotavirus Vaccines Sales Quantity Market Share by Company in 2022
Figure 81. Middle East, Africa and Latin America Rotavirus Vaccines Revenue Market Share by Company in 2022
Figure 82. Middle East, Africa and Latin America Rotavirus Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 83. Middle East, Africa and Latin America Rotavirus Vaccines Revenue Market Share by Type (2018-2034)
Figure 84. Middle East, Africa and Latin America Rotavirus Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 85. Middle East, Africa and Latin America Rotavirus Vaccines Revenue Market Share by Application (2018-2034)
Figure 86. Middle East, Africa and Latin America Rotavirus Vaccines Sales Quantity Share by Country (2018-2034)
Figure 87. Middle East, Africa and Latin America Rotavirus Vaccines Revenue Share by Country (2018-2034)
Figure 88. Brazil Rotavirus Vaccines Revenue (2018-2034) & (US$ Million)
Figure 89. Mexico Rotavirus Vaccines Revenue (2018-2034) & (US$ Million)
Figure 90. Turkey Rotavirus Vaccines Revenue (2018-2034) & (US$ Million)
Figure 91. Israel Rotavirus Vaccines Revenue (2018-2034) & (US$ Million)
Figure 92. GCC Countries Rotavirus Vaccines Revenue (2018-2034) & (US$ Million)
Figure 93. Rotavirus Vaccines Value Chain
Figure 94. Rotavirus Vaccines Production Process
Figure 95. Channels of Distribution (Direct Vs Distribution)
Figure 96. Distributors Profiles
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed